• About
  • Subscribe
  • Advertise
  • Contact
Wednesday, July 16, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Local

Good news for eyecare professionals despite cash-strapped patients downgrading private health cover

by Myles Hume
October 18, 2024
in Local, News, Ophthalmic insights, Policy & regulation
Reading Time: 3 mins read
A A
fred hollows foundation

There were almost 43,000 more optical ‘episodes’ compared to the same 2023 period. Image: RecCameraStock/sotck.adobe.com.

Share on FacebookShare on Twitter

In the face of ongoing cost-of-living pressures, Australians wanting to retain their private health insurance (PHI) are downgrading or dropping their cover, new data suggests, however more people appear to be taking up their cover for optical extras and ophthalmic procedures.

Data from the Australian Prudential Regulation Authority (APRA) has shown that while PHI membership and coverage has increased steadily throughout 2024, health fund premium revenue has decreased by $52 million in the first half of 2024. This decrease suggests policy holders are downgrading or dropping their cover as cost-of-living pressures continue to bite.

Dr Rachel David. Image: PHA.

This is according to Private Healthcare Australia (PHA), the peak body representing 98% of Australia’s private health insurance sector.

At the same time, however, the latest quarterly statistics from June 2024 shows there were almost 43,000 more optical ‘episodes’ compared to the same 2023 period. At 2,762,916, this was a 1.6% increase.

For ophthalmic procedures, such as cataract surgery, episodes increased from 111,942 to 118,078 – or 5.5% – in that timeframe.

PHA has analysed APRA’s data and found more than 216,000 policies were downgraded in the first half of 2024. A total of 14.9 million Australians currently hold some type of health insurance – 55% of the population.

The organisation’s CEO Dr Rachel David said the data showed the impact of Australia’s ongoing cost-of-living pressures.

“In the face of persistent inflation pressure, Australians continue to rely on their private health cover, with health insurance claims expenditure increasing by $2.16 billion – or 9.6% in 2023-24 compared to the previous year,” she said.

“In contrast, revenue from premiums increased by $2.04 billion in 2023-24 – a 7.5% increase compared to the previous financial year.

“The average amount returned to policy holders has also increased during the June 2024 quarter, with funds currently returning 88 cents of every premium dollar to their members. This flies in the face of recent commentary that health funds are sitting on ‘pots of gold’ in profits.”

Dr David said the trend of policies being dropped or downgraded was concerning.

“For 14.9 million Australians, private health insurance is essential, and the smallest increase on their budget – be that an increase in rent or utility costs, can have a profound impact on their access to healthcare, and in turn our health system,” she said.

Dr David said the findings came as the NSW Government threatened to increase a tax on 4 million people with health insurance in NSW to the tune of $490 million. This would add $114 to the cost of an average health insurance policy per person from next year. NSW is the only state in Australia that taxes health insurance.

“The NSW Government should review APRA’s findings closely,” she said. “The smallest increase to consumer costs can have dire, far-reaching consequences that could ultimately impact all residents of NSW seeking timely, affordable and accessible healthcare.”

Download APRA’s quarterly private health insurance performance statistics for June 2024 here.

More reading

AMA takes aim at private health’s ‘soaring management expenses’

More older Australians seeking private health first time amid longer wait times

Rise in private health insurance premiums to hit Aussie families in 2023

Related Posts

The optometry school is proposed for James Cook University. Image: EQRoy/Shutterstock.com.

New Queensland optometry school under consideration despite opposition

by Myles Hume
July 16, 2025

A new optometry school – which would be Australia’s eighth – is being proposed in North Queensland, as debate about...

The meeting – running for a third time – welcomed a record 560-plus delegates from 37 countries. Image: APSPOS.

APSPOS 2025 recap; dual Brisbane conference success for Think Business Events

by Staff Writer
July 15, 2025

The 3rd Congress of the Asia-Pacific Strabismus and Paediatric Ophthalmology Society (APSPOS), held in Brisbane from 29 June to 1...

Eye tests are just as important for people with diabetes, and KeepSight helps to facilitate these.  Image: Graphicroyalty/stock.adobe.com.

Report: KeepSight helping save vision of 560,000 Aussies

by Staff Writer
July 15, 2025

A newly released report shows that more than 560,000 Australians with diabetes are reducing their risk of blindness by over...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited